MétaCan
Menu
Back to cohort
Record W4223450106 · doi:10.1111/bjh.18170

International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn

2022· article· en· W4223450106 on OpenAlexafffund
Lani Lieberman, Enrico Lopriore, Jillian M. Baker, Rachel S. Bercovitz, Robert D. Christensen, Gemma Crighton, Meghan Delaney, Ruchika Goel, Jeanne E. Hendrickson, Amy Keir, Denise Landry, Ursula La Rocca, Brigitte Lemyre, Rolf F. Maier, Eduardo Muñiz‐Díaz, Susan Nahirniak, Helen V. New, Katerina Pavenski, Maria Cristina Santos, Glenn Ramsey, Nadine Shehata

Bibliographic record

VenueBritish Journal of Haematology · 2022
Typearticle
Languageen
FieldMedicine
TopicNeonatal Health and Biochemistry
Canadian institutionsUniversity of AlbertaUniversity of OttawaHospital for Sick ChildrenSt. Michael's HospitalUniversity Health NetworkUniversity of TorontoMount Sinai HospitalCanadian Blood ServicesHealth Sciences CentreSunnybrook Health Science Centre
FundersHealth CanadaNational Center for Advancing Translational SciencesCanadian Blood ServicesAustralian Government
KeywordsMedicineABO incompatibilityABO blood group systemHaemolytic diseaseExchange transfusionDiseaseIntensive care medicinePediatricsImmunologyInternal medicinePregnancy

Abstract

fetched live from OpenAlex

Haemolytic disease of the newborn (HDN) can be associated with significant morbidity. Prompt treatment with intensive phototherapy (PT) and exchange transfusions (ETs) can dramatically improve outcomes. ET is invasive and associated with risks. Intravenous immunoglobulin (IVIG) may be an alternative therapy to prevent use of ET. An international panel of experts was convened to develop evidence-based recommendations regarding the effectiveness and safety of IVIG to reduce the need for ETs, improve neurocognitive outcomes, reduce bilirubin level, reduce the frequency of red blood cell (RBC) transfusions and severity of anaemia, and/or reduce duration of hospitalization for neonates with Rh or ABO-mediated HDN. We used a systematic approach to search and review the literature and then develop recommendations from published data. These recommendations conclude that IVIG should not be routinely used to treat Rh or ABO antibody-mediated HDN. In situations where hyperbilirubinaemia is severe (and ET is imminent), or when ET is not readily available, the role of IVIG is unclear. High-quality studies are urgently needed to assess the optimal use of IVIG in patients with HDN.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.021
metaresearch head score (Gemma)0.045
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.021
Threshold uncertainty score0.111

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0210.045
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0030.007
Bibliometrics0.0100.008
Science and technology studies0.0010.002
Scholarly communication0.0030.002
Open science0.0040.003
Research integrity0.0050.004
Insufficient payload (model declined to judge)0.0070.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.289
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations29
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueBritish Journal of HaematologySame topicNeonatal Health and BiochemistryFrench-language works237,207